TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Onconetix ( (ONCO) ) just unveiled an announcement.
On October 23, 2025, Onconetix, Inc.’s Board of Directors decided to hold the 2025 annual meeting of stockholders on December 5, 2025, at the offices of Ellenoff Grossman & Schole LLP in New York. The company announced that shareholder proposals and director nominations for the meeting must be submitted by November 10, 2025, to be included in the proxy materials, in compliance with applicable regulations.
Spark’s Take on ONCO Stock
According to Spark, TipRanks’ AI Analyst, ONCO is a Underperform.
Onconetix’s overall score reflects substantial financial difficulties with significant operating losses and negative profitability metrics. The technical analysis suggests a bearish trend, and the valuation metrics are unfavorable due to negative earnings. These factors combine to give the stock a low attractiveness score.
To see Spark’s full report on ONCO stock, click here.
More about Onconetix
Average Trading Volume: 555,897
Technical Sentiment Signal: Sell
Current Market Cap: $5.53M
Learn more about ONCO stock on TipRanks’ Stock Analysis page.

